There were 304 cases of acute kidney injury in Indonesia by the end of October 2022.

Consumer Services & Health

Lite

Viva Budy Kusnandar 02/11/2022 13:00 WIB

URL has been copied

Memuat...

The Ministry of Health reported 304 cases of atypical progressive acute kidney injury (AKI) throughout Indonesia as of October 31, 2022. The majority of patients were aged 1-5 years.

Cases of Atypical Progressive Acute Kidney Injury (APAKI) by Age Group (October 31, 2022)

A Font Kecil
A Font Sedang
A Font Besar

Access single data

There were 304 cases of acute kidney injury in Indonesia by the end of October 2022.

Want to get more access to Data Stories with a more affordable price? Subscribe.

By subscribing, you join us in presenting quality data.

Get:

Premium Data Stories access
Comfortable reading without ads
Download data in XLS, PDF, and image format
Access to data source information

Basic

~~Rp100.000~~

Rp50.000/month

Professional

~~Rp100.000~~

Rp150.000/month

Institutional For organizations

We accept the following payments:

Some payment methods are still in the process of being activated.

Cases of Atypical Progressive Acute Kidney Injury (APAKI) by Age Group (October 31, 2022)

Download

Source

A Small Font
A Medium Font
A Bigger Font

The Ministry of Health (Kemenkes) reported 304 cases of Atypical Progressive Acute Kidney Injury (GGAPA) throughout Indonesia as of October 31, 2022.

The majority of GGAPA patients were in the 1-5 year age group, reaching 173 cases. There were 46 cases in the 0-1 year age group, 43 cases in the 6-10 year age group, and 42 cases in the 11-18 year age group.

Kemenkes spokesperson Muhammad Syahril reported that as of October 31, 2022, 99 patients (33%) had recovered. This figure is an increase compared to the previous week, where only 39 patients had recovered on October 26, 2022.

"There has been an increase this week from 20% to 33% of patients declared recovered," said Syahril, as reported by the Sehat Negeriku website on Tuesday (1/11/2022).

Meanwhile, 65 patients are still undergoing treatment, and 153 patients have died. Therefore, the mortality rate for GGAPA cases is 51%.

Kemenkes stated that it continues to strive to reduce the morbidity and mortality rates due to GGAPA, including by importing hundreds of vials of the antidote Fomepizole from Singapore, Australia, Canada, and Japan.

"146 vials have been distributed to 17 hospitals in 11 provinces, while 100 vials are stored as stock in the central pharmacy facility," said Syahril.

Editor : Adi Ahdiat

"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."